Testing effectiveness (Phase 2)Ended earlyNCT03656510
What this trial is testing
Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection
Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Research & Development, LLC 246